BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 18996970)

  • 1. The role of the mammalian copper transporter 1 in the cellular accumulation of platinum-based drugs.
    Larson CA; Blair BG; Safaei R; Howell SB
    Mol Pharmacol; 2009 Feb; 75(2):324-30. PubMed ID: 18996970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of the major copper influx transporter CTR1 to the cellular accumulation of cisplatin, carboplatin, and oxaliplatin.
    Holzer AK; Manorek GH; Howell SB
    Mol Pharmacol; 2006 Oct; 70(4):1390-4. PubMed ID: 16847145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Copper transporter 2 regulates the cellular accumulation and cytotoxicity of Cisplatin and Carboplatin.
    Blair BG; Larson CA; Safaei R; Howell SB
    Clin Cancer Res; 2009 Jul; 15(13):4312-21. PubMed ID: 19509135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of the cellular pharmacology of JM118, the major metabolite of satraplatin, by copper influx and efflux transporters.
    Samimi G; Howell SB
    Cancer Chemother Pharmacol; 2006 Jun; 57(6):781-8. PubMed ID: 16170571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The copper transporter CTR1 regulates cisplatin uptake in Saccharomyces cerevisiae.
    Lin X; Okuda T; Holzer A; Howell SB
    Mol Pharmacol; 2002 Nov; 62(5):1154-9. PubMed ID: 12391279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Copper transporters and the cellular pharmacology of the platinum-containing cancer drugs.
    Howell SB; Safaei R; Larson CA; Sailor MJ
    Mol Pharmacol; 2010 Jun; 77(6):887-94. PubMed ID: 20159940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired cisplatin influx in an A2780 mutant cell line: evidence for a putative, cis-configuration-specific, platinum influx transporter.
    Helleman J; Burger H; Hamelers IH; Boersma AW; de Kroon AI; Stoter G; Nooter K
    Cancer Biol Ther; 2006 Aug; 5(8):943-9. PubMed ID: 16775422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of copper transporter 2 expression by copper and cisplatin in human ovarian carcinoma cells.
    Blair BG; Larson CA; Adams PL; Abada PB; Safaei R; Howell SB
    Mol Pharmacol; 2010 Jun; 77(6):912-21. PubMed ID: 20194531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cisplatin rapidly down-regulates its own influx transporter hCTR1 in cultured human ovarian carcinoma cells.
    Holzer AK; Katano K; Klomp LW; Howell SB
    Clin Cancer Res; 2004 Oct; 10(19):6744-9. PubMed ID: 15475465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor platinum concentration following intraperitoneal administration of cisplatin versus carboplatin in an ovarian cancer model.
    Jandial DD; Messer K; Farshchi-Heydari S; Pu M; Howell SB
    Gynecol Oncol; 2009 Dec; 115(3):362-6. PubMed ID: 19775736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Copper transporters regulate the cellular pharmacology and sensitivity to Pt drugs.
    Safaei R; Howell SB
    Crit Rev Oncol Hematol; 2005 Jan; 53(1):13-23. PubMed ID: 15607932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expression of copper transporters associated with the ototoxicity induced by platinum-based chemotherapeutic agents.
    Perde-Schrepler M; Fischer-Fodor E; Virag P; Brie I; Cenariu M; Pop C; Valcan A; Gurzau E; Maniu A
    Hear Res; 2020 Mar; 388():107893. PubMed ID: 32006874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contributions of rat Ctr1 to the uptake and toxicity of copper and platinum anticancer drugs in dorsal root ganglion neurons.
    Liu JJ; Kim Y; Yan F; Ding Q; Ip V; Jong NN; Mercer JF; McKeage MJ
    Biochem Pharmacol; 2013 Jan; 85(2):207-15. PubMed ID: 23123662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The copper export pump ATP7B modulates the cellular pharmacology of carboplatin in ovarian carcinoma cells.
    Katano K; Safaei R; Samimi G; Holzer A; Rochdi M; Howell SB
    Mol Pharmacol; 2003 Aug; 64(2):466-73. PubMed ID: 12869652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of human copper transporter Ctr1 in the transport of platinum-based antitumor agents in cisplatin-sensitive and cisplatin-resistant cells.
    Song IS; Savaraj N; Siddik ZH; Liu P; Wei Y; Wu CJ; Kuo MT
    Mol Cancer Ther; 2004 Dec; 3(12):1543-9. PubMed ID: 15634647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of effects of copper histidine on copper transporter 1-mediated accumulation of platinum and oxaliplatin-induced neurotoxicity in vitro and in vivo.
    Ip V; Liu JJ; McKeage MJ
    Clin Exp Pharmacol Physiol; 2013 Jun; 40(6):371-8. PubMed ID: 23556474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Claudin-3 and claudin-4 regulate sensitivity to cisplatin by controlling expression of the copper and cisplatin influx transporter CTR1.
    Shang X; Lin X; Manorek G; Howell SB
    Mol Pharmacol; 2013 Jan; 83(1):85-94. PubMed ID: 23053666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of copper transporters in the uptake and efflux of platinum containing drugs.
    Safaei R
    Cancer Lett; 2006 Mar; 234(1):34-9. PubMed ID: 16297532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relevance of copper transporter 1 for cisplatin resistance in human ovarian carcinoma cells.
    Kalayda GV; Wagner CH; Jaehde U
    J Inorg Biochem; 2012 Nov; 116():1-10. PubMed ID: 23010323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the N-terminus of mammalian copper transporter 1 in the cellular accumulation of cisplatin.
    Larson CA; Adams PL; Jandial DD; Blair BG; Safaei R; Howell SB
    Biochem Pharmacol; 2010 Aug; 80(4):448-54. PubMed ID: 20451502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.